::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

DURING THE COVID-19 OUTBREAK REDEFINING DIALYSIS FACILITY RECOMMENDATIONS FOR INFECTION CONTROL AND PREVENTION: A STUDY IN FAUJI FOUNDATION HOSPITAL RAWALPINDI PAKISTAN

AUTHORS:

Dr Tania Saif, Dr Fatima Naz Awan, Dr Maria Tariq,

ABSTRACT:

In Wuhan a city of china, reported cases of pneumonia having unknown etiology in December 2019. The clinical symptoms of these reported cases were alike viral pneumonia. People’s of Republic China Disease Control Centers analyzed the respiratory samples and declared that the main cause behind the reported cases was a highly contagious coronavirus (SARS-CoV-2). A public health emergency was declared by WHO due to this ongoing outbreak. Moreover, due to the lack of knowledge of pharmaceutical intervention on this virus, the only strategy used to lessen the reported cases was to reduce the interaction between infectious and healthy people. In India, America, Europe, Japan, India, and South Korea the reported cases have rapidly increasing over the last month. In the region of Middle East new cases are being reported. This scenario is creating critical problems for the patients of Hemodialysis who need regular sessions of hemodialysis after three weeks. In this report the opinions of various nephrologists are presented as a guideline which will serve the community of nephrology so that they can deal with impending danger. Keywords: Covid-19, Hemodialysis